Biopharma Daily Stock Updates - 07/23/21
$XBI $126 -1%
Covid Updates
$CRTX -1% Cortexyme Announces Lead 3CLpro Inhibitor for the Treatment of Coronavirus Infection. source
Pipeline Updates
$TNXP -35% Tonix Pharmaceuticals Announces Outcome of Interim Analysis of Phase 3 RALLY Study of TNX-102 SL for the Management of Fibromyalgia. source
$SRNE -6% Lee’s Pharmaceutical Announces First Patient Dosed With its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, as a First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer. source
$RDUS -2% CORRECTION: Radius Health Announces Plans for Global Prader-Willi Syndrome Pivotal Study. source
$OCUL +2% OCULAR THERAPEUTIX™ TO PRESENT CLINICAL DATA AT THE 2021 AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY (ASCRS) ANNUAL MEETING. source
$ABEO -4% Abeona Therapeutics Activates Second Clinical Trial Site in EB-101 Pivotal Phase 3 VIITAL™ Study for Recessive Dystrophic Epidermolysis Bullosa. source
Financial Updates
$CYTK -1% Closed public offering.
Posted by DV
Comments